Effects of Docosahexanoic Acid on Neurocognitive Impairment in HIV-infected Patients
NCT04242004
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
88
Enrollment
OTHER
Sponsor class
Conditions
Neurocognitive Impairment
Interventions
DRUG:
Docosahexaenoic acid (DHA) capsules
DIETARY_SUPPLEMENT:
Soy oil capsules
Sponsor
Fudan University